CLINICAL_TRIALS
trial_result
· 2021-03-02
Clinical Trial Update: Stimgenics Open-Label, Post Market Study [NA]
Summary
Post-market open-label study completed for chronic low back pain; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Stimgenics LLC | Conditions: Chronic Low Back Pain | NA | Status: COMPLETED | Results posted: 2021-03-02